IRIS
AIMO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.212
AS - Asia 12.564
EU - Europa 12.470
SA - Sud America 3.803
AF - Africa 315
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 21
Totale 53.418
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.200
SG - Singapore 5.440
RU - Federazione Russa 4.841
BR - Brasile 3.118
CN - Cina 3.006
IT - Italia 2.478
GB - Regno Unito 1.607
VN - Vietnam 1.576
DE - Germania 981
HK - Hong Kong 885
CA - Canada 714
UA - Ucraina 432
IE - Irlanda 429
SE - Svezia 295
AR - Argentina 272
FI - Finlandia 271
IN - India 271
FR - Francia 225
MX - Messico 217
TR - Turchia 216
PL - Polonia 203
BD - Bangladesh 186
ID - Indonesia 183
NL - Olanda 175
IL - Israele 165
ZA - Sudafrica 148
ES - Italia 144
EC - Ecuador 139
JP - Giappone 131
IQ - Iraq 102
PK - Pakistan 96
AT - Austria 94
DK - Danimarca 69
CO - Colombia 68
AE - Emirati Arabi Uniti 57
LT - Lituania 55
MA - Marocco 50
PY - Paraguay 50
UZ - Uzbekistan 49
VE - Venezuela 44
CL - Cile 33
PE - Perù 32
BE - Belgio 28
KE - Kenya 27
CH - Svizzera 26
UY - Uruguay 26
EG - Egitto 25
SA - Arabia Saudita 22
TN - Tunisia 21
AZ - Azerbaigian 19
RO - Romania 18
EU - Europa 17
IR - Iran 17
CZ - Repubblica Ceca 16
DO - Repubblica Dominicana 16
AU - Australia 15
JO - Giordania 15
DZ - Algeria 14
BO - Bolivia 13
KZ - Kazakistan 12
NZ - Nuova Zelanda 11
NP - Nepal 10
AL - Albania 9
CR - Costa Rica 9
HN - Honduras 9
LB - Libano 9
MY - Malesia 9
NI - Nicaragua 9
AM - Armenia 8
KR - Corea 8
MC - Monaco 8
OM - Oman 8
TW - Taiwan 8
GE - Georgia 7
GT - Guatemala 7
GY - Guiana 7
PA - Panama 7
SK - Slovacchia (Repubblica Slovacca) 7
TH - Thailandia 7
BB - Barbados 6
BY - Bielorussia 6
CI - Costa d'Avorio 6
HU - Ungheria 6
KG - Kirghizistan 6
PH - Filippine 6
TT - Trinidad e Tobago 6
JM - Giamaica 5
PT - Portogallo 5
BA - Bosnia-Erzegovina 4
KW - Kuwait 4
MD - Moldavia 4
ML - Mali 4
PS - Palestinian Territory 4
SI - Slovenia 4
AO - Angola 3
BG - Bulgaria 3
BH - Bahrain 3
BN - Brunei Darussalam 3
GR - Grecia 3
HR - Croazia 3
Totale 53.345
Salva come PNG Salva come JPEG
Città #
Dallas 6.173
Singapore 2.893
Ashburn 1.492
Chicago 1.422
Beijing 1.387
Los Angeles 1.172
Moscow 906
Hong Kong 826
Salt Lake City 606
Chandler 562
Southend 543
Ho Chi Minh City 515
Fairfield 462
San Mateo 451
Buffalo 426
Dublin 423
Houston 384
Woodbridge 359
Wilmington 355
Hefei 350
New York 350
Tampa 345
The Dalles 343
São Paulo 323
Cambridge 320
Seattle 304
Elk Grove Village 269
Hanoi 258
Milan 254
Boardman 250
Portsmouth 242
Falls Church 237
Munich 234
Stevenage 215
Ann Arbor 212
Santa Clara 212
Rome 207
Ottawa 203
Pisa 200
Beauharnois 193
Warsaw 181
Jacksonville 179
Brooklyn 157
Dearborn 156
Lawrence 155
Tel Aviv 147
Montreal 146
Florence 143
London 133
Sterling 133
Istanbul 128
Lancaster 126
Dong Ket 117
Tokyo 116
Stockholm 115
Poplar 114
Denver 109
Frankfurt am Main 108
Rio de Janeiro 105
Johannesburg 99
Chennai 98
Nuremberg 96
Phoenix 96
Lappeenranta 95
Mexico City 95
Orem 95
Miami 93
Atlanta 87
Boston 86
Helsinki 84
Belo Horizonte 78
Dulles 78
Toronto 72
Turku 70
San Diego 64
Amsterdam 60
Brasília 58
Haiphong 57
Manchester 57
Ankara 56
Bologna 53
Detroit 53
San Francisco 53
Curitiba 52
Porto Alegre 52
Kansas City 51
Guangzhou 50
Washington 50
Da Nang 49
Council Bluffs 48
Mumbai 47
Quito 47
Biên Hòa 46
Lucca 45
Campinas 44
Guayaquil 44
Pittsburgh 43
Querétaro 43
Tashkent 43
Naples 42
Totale 32.075
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.792
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.594
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.508
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 828
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 659
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 550
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 403
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 330
Building medical knowledge from real world registries: The case of heart failure 312
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 309
A simple echocardiographic score to rule out cardiac amyloidosis 305
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 303
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 294
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 293
Treating chemoreflex in heart failure: modulation or demolition? 291
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 285
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 283
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 279
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 278
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 275
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 267
Position paper ANMCO: Impiego di vericiguat nello scompenso cardiaco: dalle evidenze al posizionamento terapeutico 260
A simple echocardiographic score to rule out cardiac amyloidosis 256
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 252
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 247
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 246
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 239
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 236
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 235
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 235
Sex-related differences in chronic heart failure 234
How to take arms against central apneas in heart failure 233
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 232
Cardiac light-chain deposition disease relapsing in the transplanted heart 231
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 227
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead 225
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 224
Unmet needs in end-of-life care for heart failure patients 222
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 222
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 220
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 220
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 218
Screening the health status of people working in a university 217
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 217
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 217
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 216
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 212
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 212
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 212
Exercise intolerance in heart failure with preserved ejection fraction: A reappraisal of central mechanisms? 210
[Ten perspectives for research and innovation in cardiac amyloidosis] 209
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 208
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 207
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 206
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 206
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 205
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 205
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 205
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 205
Atrial amyloidosis: mechanisms and clinical manifestations 201
Biomarkers for the diagnosis and management of heart failure 201
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 200
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 199
Cardiac troponins as biomarkers for cardiac disease 195
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 194
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 193
Biomarkers for the diagnosis and management of heart failure: New frontiers 192
Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox 191
Cardiovascular disease and COVID-19: les liaisons dangereuses 190
Eligibility for vericiguat in a real‐world, contemporary heart failure population 188
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 188
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 187
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 184
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 184
Amiodarone as a possible therapy for coronavirus infection 183
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 182
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 179
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 179
Role of Imaging in Cardiomyopathies 178
The Importance of Visceral Feedbacks: Focus on Chemoreceptors 178
Cardiac magnetic resonance in patients with muscular dystrophies 178
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 177
Beta-blocking patients with cardiac amyloidosis: Adelante cum juicio 177
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 174
Management of complications of cardiac amyloidosis: 10 questions and answers 174
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure 174
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 174
Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis 172
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 171
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi 171
Subclinical cardiac damage in cancer patients before chemotherapy 170
Valvular heart disease in patients with cardiac amyloidosis 169
Remote Ischemic Conditioning in Ischemic Stroke and Myocardial Infarction: Similarities and Differences 169
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 168
Perspectives in noninvasive imaging for chronic coronary syndromes 168
Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week 168
Factors for heterogeneous outcomes of angina and myocardial ischemia without obstructive coronary atherosclerosis 168
Molecular autopsy of sudden cardiac death in the genomics era 168
Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis 167
Disease features and management of cardiomyopathies in women 167
Totale 27.311
Salva come PNG Salva come JPEG
Categoria #
all - tutte 294.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 294.659
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.541 0 0 0 0 0 321 143 129 217 158 252 321
2021/20222.538 177 295 65 231 108 145 298 491 203 285 52 188
2022/20231.732 162 165 75 154 210 208 42 155 341 43 121 56
2023/20241.762 107 49 336 122 75 154 106 71 88 96 95 463
2024/202519.303 220 243 878 362 665 803 1.951 3.264 1.352 2.531 4.186 2.848
2025/202624.047 2.194 6.182 4.866 5.533 4.011 1.261 0 0 0 0 0 0
Totale 53.815